Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
Open on the live globe →Who reported it
- 2026-10-20 12:50 UTCCNBC · cnbc.com ↗
More from Denmark
- Denmark tests humanoid robots in supermarkets to help to ease staff workload at night 2 sources
- Denmark pushes back as Trump touts Greenland oil and mineral deals 2 sources
- Denmark and Vietnam at 55: From Development Cooperation to a Green Partnership 2 sources
- Top Vietnamese leader receives Denmark's highest-ranked honor 1 source
- Social Democrat warns foreign labor risks creating master-servant society 1 source
- Lego named Denmark’s most valuable brand at 114 billion DKK 1 source
- MobilePay launches digital proof of age for use in Danish stores 1 source
- Pensioners occupy Aarhus rehabilitation center to protest closure 1 source